Abstract:Background: Sjogren's syndrome (SS) is a chronic inflammatory autoimmune disease mainly characterized by dryness, fatigue, and pain. Current therapies for SS in Western medicine are limited. The purpose of this clinical study was to explore the efficacy and safety of using a traditional Chinese medicine (TCM) formula on patients with primary SS. Methods: We performed a 12-week, randomized, double-blinded, placebo-controlled clinical trial at Chung Shan Medical University Hospital. We included 42 patients with SS between the ages of 20 and 80 years who met the classification criteria of the American and European Consensus Group (AECG). Patients who had other severe systemic manifestations or diseases were excluded from this trial. After screening, patients were randomly assigned to the TCM treatment group or placebo group (ratio of 2:1). We treated the TCM group with 6 g of Gan-Lu-Yin granules after breakfast and 6 g of Jia-Wei-Xiao-Yao-San combined with 1 g of Suan-Zao-Ren-Tang and 1 g of Ye-Jiao-Teng every night after dinner. Patients in the control group were treated with a placebo with the same appearance and flavor but only one-tenth the dosage of that received by the treatment group. The European League Against Rheumatism Sjogren's Syndrome Patient-Reported Index (ESSPRI) was used as the primary endpoint at week 12. Secondary endpoints were the Sjogren's Syndrome Disease Activity Index (SSDAI), physician global assessment (PGA), visual analogue scale (VAS), Multidimensional Fatigue Inventory, Medical Outcomes Survey Short Form-36, and the Pittsburgh Sleep Quality Score (PSQI). Adverse events were also recorded. Results: Of the 42 randomized patients, 28 patients were assigned to the TCM treatment group and 14 patients were assigned to the controlled group. During the study period, 5 patients withdrew from the TCM group and 7 withdrew from the control group. At week 12, the ESSPRI scores of both groups had improved. The ESSPRI score of the treatment group decreased by 0.62 (95% CI P = 0.557) and that of the placebo group decreased by 0.91 ( P = 0.557). However, no significant difference was observed between the two groups. Sleep duration in the PSQI was −0.61, which exhibited an improvement of more than the −0.21 compared with the placebo group ( P = 0.914). Conclusion: At week 12, the ESSPRI scores did not reveal that the use of the TCM formula was efficacious for treating patients with Sjogren's syndrome. However, the PSQI scores indicated that this formula could prolong patient sleep duration. We also found that this formula could decrease the blood pressure of patients.

Clinical research on treating SS by three formulations of transfer factor plus TCM

Total Glucosides of Peony Ameliorates Sjögren's Syndrome by Affecting Th1/Th2 Cytokine Balance.

[Effects of Chinese Herbal Medicine for Yiqi Yangyin Quyu in Treating Sjögren's Syndrome and on Patients' Immunologic Function].

Therapeutic Effect of Chinese Herbal Medicine for Strengthening Qi, Nourishing Yin, and Removing Stasis on Serum Osteopontin and Quality of Life of Patients with Primary Sjogren'S Syndrome

[Effect of Prescriptions Replenishing Vital Essence, Tonifying Qi and Activating Blood on TNF-alpha, IL-1beta Expressions in Serum and Submaxillary Gland of NOD Mice with Sjogren's Syndrome].

A Combination of UPLC-LTQ-Orbitrap-MSn Research, Network Analysis and Experimental Verification Used to Explore the Mechanism of Yangyin Yiqi Huoxue Recipe in Treating Sjogren’s Syndrome

Effect of Chinese Herbal Medicines for Nourishing Yin, Supplementing Qi, and Activating Blood on Reproductive Endocrine Activity and Immune Functions in Patients with Primary Sjogren's Syndrome.

Traditional Chinese Medicine in Patients With Primary Sjogren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Clinical Observation of Acupuncture and TCM in Treatment of 30 cases Primary Sjogren Syndrome

Clinical research to treat chronic eczema with modified Siwu Xiaofeng powder plus sicortend

Clinical Study on Erteng Tongbi Mixture Plus Zhengqing Fengtongning Sustained Released Tablet in the Treatment of Rheumatoid Arthritis:A Report of 30 Cases

Traditional Chinese medicine for sjögren's syndrome: a national survey of attitudes and perceptions among Chinese patients and rheumatologists

Clinical Study on Cough Variant Asthma Treated with Shufeng Zhisou Formula

Clinical Observation on the Effect of Tongbi Heji Plus Syndrome Differentiation Treatment for 90 Rheumatoid Arthritis Patients

Clinical Study on 22 Rheumatoidarthritis Patients Treated with Optimum Proposal of Integration of Disease and TCM Syndrome

Clinical Study on the Therapeutic Effect of Fengshi Zhengtong Pill in Treating RA Patients Who Were Type of Cold Wetness Blocked in Joints

The Effect of Trichosanthin on Immunoregulatory T Lymphocytes

Identification of Fangji Huangqi Tang As a Potential Herbal Formula for Sjogren Syndrome Treatment Via Network Pharmacology and Experimental Validation.

Clinical and immunological consequences of total glucosides of paeony treatment in Sjögren's syndrome: A randomized controlled pilot trial

Herbal Formula SS-1 Increases Tear Secretion for Sjögren’s Syndrome

Scientific Basis of Using Similar Treatment Method for Treating Different Diseases as Identical Syndrome